RNAi therapeutics (Dicerna Pharmaceuticals/Novo Nordisk)

N/A

Report date: 2023/01/08 14:03:56
NME

Base Information

Drug NameRNAi therapeutics (Dicerna Pharmaceuticals/Novo Nordisk)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsMetabolic DiseasesCardiovascular DiseasesLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDicerna Pharmaceuticals IncNovo Nordisk Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk IncDicerna Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesCardiovascular DiseasesLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A